Amwell Stock Enters Tuesday, Aug. 4 Earnings Release With a Platform, a Market, and Something to Prove -( $AMWL ) by John F. Heerdink, Jr. 2 hours ago Read more The Million‑Patient Question: Is Eupraxia’s EP‑104GI Ready To Turn EoE Endoscopy Into A Business Model? -( $EPRX $SNY $XBI ) by John F. Heerdink, Jr. 4 days ago Read more July 30, 2026 | Markets Rally as GDP Hits the Brakes: Wall Street Decides ‘Soft Landing’ Is Still In Style -( $AMWL $AMZN $EPRX $FMC $HPP $LPL $MSFT $SKHY $SMWB $YSG Rise!) by John F. Heerdink, Jr. 4 days ago Read more Amwell’s Executive Bench Suggests Telehealth Is Growing Up -( $AMWL $TDOC $SMWB ) by John F. Heerdink, Jr. July 27, 2026 Read more Eli Lilly-Backed Scribe Therapeutics Stuns Wall Street With a Rare Gene-Editing IPO -( $LLY $SCTX $SNY ) by John F. Heerdink, Jr. July 25, 2026 Read more Defense, Rates, and Diabetes Tech: Three Very Different Signals With One Message -( $LMT $MODD ) by John F. Heerdink, Jr. July 23, 2026 Read more Repligen’s $1.5B BioLife Acquisition Fits a Bigger Shift in Biotech M&A -( $BLFS $JPM $RGEN ) by John F. Heerdink, Jr. July 22, 2026 Read more Paging Dr. Cash Flow: Doximity Turns Clinical AI Into A Profitable House Call -( $DOCS ) by John F. Heerdink, Jr. July 21, 2026 Read more Not Your Grandfather’s Diabetes Kit: Eli Lilly’s Smart Ring Bet and Modular Medical’s Pivot Pump Rewire the Care Stack -( $LLY $MODD ) by John F. Heerdink, Jr. July 21, 2026 Read more The Esophagus Economy: How EP‑104GI Could Reshape EoE Treatment—and Eupraxia’s Valuation -( $EPRX $REGN $SNY ) by John F. Heerdink, Jr. July 20, 2026 Read more Read more
